Search

Search Results

• The Role of Polymorphic Variants of Р450 Cytochrome Genes as well as Genes GSTP1 and MDR1 in Toxic Complications of Program Drug Chemotherapy for Classical Hodgkin Lymphoma

  Yana Yurevna Shebunyaeva

  141-153

  01.04.2024

• Therapy Optimization in Newly Diagnosed Diffuse Large B-Cell Lymphoma: Efficacy and Safety of the R-SD-EPOCH ± HDMTX Program Under Single-Center Non-Randomized Prospective Clinical Trial (Preliminary Results)

  Marat Albertovich Mingalimov

  173-179

  01.04.2024

• Risk Factors for Relapses of Perianal Infectious Complications in Patients with Hematological Malignancies: Results of a Single-Center Prospective Trial

  Svetlana Vitalevna Shtyrkova, K.I. Danishyan, E.N. Parovichnikova

  204-212

  01.04.2024

• Primary Prevention of Neutropenia by Empegfilgrastim in Patients with Advanced Stages of Classical Hodgkin Lymphoma Treated with Intensive First-Line Chemotherapy with a Modified 6-Cycle Program EACODD-14 Under the Protocol “LKh-Rossiya-1”

  Anna Anatolevna Spornik, N.S. Vasilev, A.A. Samoilova, A.A. Mamedova, V.S. Bogatyrev, E.G. Smirnova, A.A. Bannikova, A.A. Rukavitsyn, N.S. Shorokhov, N.E. Mochkin, V.O. Sarzhevskii, E.A. Demina, V.Ya. Melnichenko

  370-379

  28.09.2023

• Follicular Lymphoma of Grades 1–3А With and Without t(14;18)(q32;q21): A Prognosis, Choice of Chemotherapy and Its Outcomes

  Ekaterina Sergeevna Nesterova, E.E. Zvonkov, A.M. Kovrigina, T.N. Obukhova, B.V. Biderman, A.B. Sudarikov, Ya.K. Mangasarova, A.U. Magomedova, A.K. Smolyaninova, S.M. Kulikov, E.N. Parovichnikova

  361-369

  28.09.2023

• Supportive Therapy in Multiple Myeloma: Practical Recommendations

  Maksim Valerevich Solovev, M.V. Soloveva, L.P. Mendeleeva

  426-448

  28.09.2023

• Cardiovascular Complications of the Immunotherapy of Hematological Malignancies: A Literature Review

  Geliya Rifkatovna Gimatdinova, O.E. Danilova, V.P. Kuzmin, G.I. Davydkin, Yu.V. Kostalanova, D.A. Kudlai, I.L. Davydkin

  407-412

  28.09.2023

• BAALC-Expressing Leukemia Hematopoietic Stem Cells and Their Place in the Study of CBF-Positive Acute Myeloid Leukemias in Children and Adults

  M.M. Kanunnikov, Nikolai Nikolaevich Mamaev, T.L. Gindina, A.I. Shakirova, A.M. Sadykov, S.V. Razumova, S.N. Bondarenko, L.S. Zubarovskaya

  387-398

  28.09.2023

• New Approaches to Cardiovascular Toxicity Assessment in Patients with Hematological Malignancies: A Literature Review

  O.E. Danilova, Geliya Rifkatovna Gimatdinova, I.L. Davydkin, O.V. Tereshina, V.D. Sabanova, G.I. Davydkin

  331-336

  09.06.2023

• Multiple Myeloma Complicated by Bone Plasmacytomas: Pathogenesis, Clinical Features, Treatment Approaches (A Literature Review)

  Elizaveta Andreevna Mamaeva, M.V. Solov’eva, L.P. Mendeleeva

  303-310

  09.06.2023

• Expression of the WNT Family Genes in Multiple Myeloma Patients with Different Chemotherapy Response

  Natella Iosifovna Enukashvili, L.A. Belik, I.I. Kostroma, N.Yu. Semenova, V.A. Balashova, D.V. Baram, S.V. Gritsaev, S.S. Bessmeltsev, S.V. Sidorkevich, I.S. Martynkevich

  294-302

  09.06.2023

• Efficacy of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients Aged over 60 Years

  Ivan Ivanovich Kostroma, V.A. Yudina, R.R. Sabitova, E.S. Stepchenkova, Zh.V. Chubukina, S.S. Bessmeltsev, S.V. Sidorkevich, S.V. Gritsaev

  287-293

  09.06.2023

• Nivo-BeGEV as Preparation for Autologous Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Classical Hodgkin Lymphoma: Results of a Multi-Center Prospective Clinical Study

  Yana Konstantinovna Mangasarova, T.N. Moiseeva, O.V. Margolin, L.G. Gorenkova, E.S. Nesterova, F.E. Babaeva, M.O. Bagova, E.A. Fastova, R.R. Abdurashidova, L.S. Al-Radi, E.I. Dorokhina, E.M. Volodicheva, V.A. Lapin, O.S. Samoilova, S.K. Kravchenko, A.U. Magomedova, E.E. Zvonkov

  280-286

  09.06.2023

• Dynamics of SARS-CoV-2 RNA Detection in Patients and Employees of the National Research Center for Hematology During the First Two Years of the Novel COVID-19 Pandemic

  Oksana Gazimagomedovna Starkova, D.S. Tikhomirov, A.Yu. Krylova, I.O. Snezhko, E.N. Ovchinnikova, O.A. Aleshina, T.A. Tupoleva, T.V. Gaponova

  186-191

  03.03.2023

• Long-Term Results of Classical Hodgkin’s Lymphoma Treatment in Real-World Clinical Practice: Experience of Novosibirsk Hematological Unit

  Mariya Sergeevna Voitko, T.I. Pospelova, I.N. Nechunaeva, Ya.Yu. Shebunyaeva

  192-199

  03.03.2023

• T-Helper Subpopulations in Acute Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation

  Yuliya Olegovna Davydova, N.M. Kapranov, K.A. Nikiforova, O.S. Karavaeva, D.V. Kamelskikh, M.Yu. Drokov, L.A. Kuzmina, T.V. Gaponova, I.V. Galtseva, E.N. Parovichnikova

  137-145

  03.03.2023

• Efficacy and Toxicity of Induction Therapy in Patients with Newly Diagnosed Systemic AL Amyloidosis: Results of a Prospective Single-Center Clinical Study

  I.G. Rekhtina, Viktoriya Aleksandrovna Khyshova, M.V. Solov’ev, L.P. Mendeleeva

  166-173

  03.03.2023

• Identification of Somatic Mutations in EZH2 Gene and Assessment of Their Prognostic Value in Follicular Lymphoma Grades 1–3А

  Ekaterina Sergeevna Nesterova, N.A. Severina, B.V. Biderman, A.B. Sudarikov, A.M. Kovrigina, T.N. Obukhova, Ya.K. Mangasarova, S.M. Kulikov, E.E. Zvonkov, E.N. Parovichnikova, V.G. Savchenko

  80-87

  01.01.2023

• Characteristic Features of the Novel Coronavirus Infection COVID-19 in Oncohematological Patients

  Nikolai Aleksandrovich Romanenko, E.R. Shilova, L.V. Stelmashenko, E.I. Kaitandzhan, A.V. Kuleshova, N.P. Stizhak, V.N. Chebotkevich, S.V. Sidorkevich, S.V. Gritsaev, S.S. Bessmeltsev

  101-108

  01.01.2023

• Chronic Hepatitis С and Oncohematological Diseases

  Tamara Vasilevna Antonova, M.S. Nozhkin, D.A. Lioznov

  46-53

  01.01.2023

• Efficacy of Combined Drug Pre-transplant Conditioning Regimens in Multiple Myeloma Patients with Single Autologous Hematopoietic Stem Cell Transplantation

  Ivan Ivanovich Kostroma, A.S. Zhuk, Zh.Yu. Sidorova, R.R. Sabitova, A.Yu. Aksenova, O.B. Belopolskaya, S.S. Bessmeltsev, S.V. Sidorkevich, S.V. Gritsaev

  88-95

  01.01.2023

• Experience with the Use of B-RAF Inhibitor Vemurafenib in the Treatment of Hairy Cell Leukemia

  L.S. Al-Radi, Svetlana Yurevna Smirnova, T.N. Moiseeva, I.S. Piskunova, L.V. Plastinina, D.V. Novikova, E.G. Gemdzhian, G.M. Galstyan

  349-355

  01.10.2022

• Plasmablastic Lymphoma with Primary Impairment of Bone Marrow in a HIV-Negative Patient: A Literature Review and a Case Report

  Maiya Valerevna Firsova, M.V. Solov’ev, A.M. Kovrigina, L.P. Mendeleeva

  356-364

  01.10.2022

• Efficacy and Safety of Pola-BR Combination in Relapsed/Refractory Aggressive В-Cell Non-Hodgkin’s Lymphomas: A Russian Multi-Center Study

  Olesya Gennadevna Smykova, A.A. Semenova, Yu.B. Chernykh, T.A. Mitina, A.V. Kildyushevskii, S.K. Kravchenko, A.E. Misyurina, A.U. Magomedova, E.A. Baryakh, S.V. Samarina, N.P. Volkov, V.V. Markelov, P.V. Kotselyabina, L.V. Fedorova, K.V. Lepik, E.V. Kondakova, L.V. Stelmakh, V.V. Baykov, N.B. Mikhailova, I.S. Moiseev, G.S. Tumyan, E.A. Osmanov, A.D. Kulagin

  232-239

  01.07.2022

• Efficacy and Safety of Midostaurin Combined with Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia with FLT3 Mutation

  Sergei Nikolaevich Bondarenko, A.G. Smirnova, B.I. Ayubova, E.V. Karyagina, O.S. Uspenskaya, Yu.S. Neredko, A.P. Kochergina, I.A. Samorodova, E.A. Pashneva, Yu.S. Chernykh, Yu.A. Dunaev, N.B. Esef’eva, R.K. Il’yasov, T.I. Brazhkina, I.A. Novokreshchenova, Z.K. Simavonyan, E.I. Kuzub, V.I. Bakhtina, T.I. Olkhovich, M.V. Burundukova, E.V. Babenko, Yu.D. Oleinikova, I.M. Barkhatov, T.L. Gindina, I.S. Moiseev, A.D. Kulagin

  167-175

  01.04.2022

• Pharmacoeconomic Analysis of CAR-T Cell Therapy in Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemias

  Irina Vladimirovna Gribkova, A.A. Zavyalov

  205-212

  01.04.2022

• Plasmablastic Lymphoma in HIV-Positive Patients: A Literature Review and Results of a Russian Multi-Center Retrospective Study

  Marina Olegovna Popova, I.V. Tsygankov, Ya.V. Gudozhnikova, Yu.A. Rogacheva, N.P. Volkov, K.V. Lepik, M.V. Demchenkova, M.V. Grigoreva, A.Yu. Efirkina, T.V. Shneider, Yu.V. Kopeikina, S.A. Stepanova, V.G. Potapenko, A.V. Klimovich, N.V. Medvedeva, M.A. Kolesnikova, T.I. Pospelova, N.B. Mikhailova, V.V. Baikov, A.D. Kulagin

  28-41

  01.01.2022

• The Efficacy of Brentuximab Vedotin in Relapsed/Refractory Classical Hodgkin’s Lymphoma and Quality of Life: Results of a Multi-Center Observational Prospective Study in the Context of Real Clinical Practice

  T.I. Ionova, A.A. Amdiev, M.I. Andrievskikh, E.A. Baryakh, E.V. Vasilev, M.V. Volkov, E.M. Volodicheva, V.V. Ivanov, O.V. Kaverina, K.D. Kaplanov, T.Yu. Klitochenko, V.I. Kurakin, D.G. Lazareva, O.G. Larionova, K.V. Lepik, I.B. Lysenko, V.Ya. Melnichenko, R.I. Minullina, O.V. Mironov, E.N. Misyurina, N.B. Mikhailova, N.E. Mochkin, Tatyana Pavlovna Nikitina, T.S. Petrova, N.M. Porfireva, O.A. Rukavitsyn, A.A. Samoilova, R.N. Safin, P.I. Simashova, E.G. Smirnova, N.A. Trenina, N.V. Fadeeva, G.N. Khusainova, V.L. Chang, T.V. Shelekhova, D.G. Sherstnev

  42-53

  01.01.2022

• Current State of Diagnosis and Treatment of Acute Myeloid Leukemias in Adult Patients in the Republic of Kazakhstan

  A.A. Klodzinskii, I.A. Pivovarova, L.G. Turgunova, Aimzhan Zharkynovna Anafina, A.V. Zinchenko

  69-75

  01.01.2022

• Pharmacoeconomic Analysis of Gilteritinib in the Therapy of Adult Patients with Relapsed/Refractory Acute Myeloid Leukemias with FLT3 Mutation

  A.S. Kolbin, Yuliya Mikhailovna Gomon, Yu.E. Balykina, M.A. Proskurin

  85-96

  01.01.2022

• Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma with Renal Impairment

  Maiya Valerevna Firsova, L.P. Mendeleeva, M.V. Solov’ev, D.A. Mironova, L.A. Kuzmina, V.G. Savchenko

  97-106

  01.01.2022

• Results of the Russian Multi-Center Cooperative Prospective-Retrospective Observational Program for Hodgkin’s Lymphoma Treatment RNWOHG-HD1

  Ivan Sergeevich Moiseev, S.M. Alekseev, N.B. Mikhailova, K.D. Kaplanov, M.V. Demchenkova, L.V. Anchukova, V.V. Baikov, A.M. Belyaev, Yu.A. Vasil’eva, N.P. Volkov, Yu.N. Vinogradova, A.Yu. Zaritskey, A.E. Zdorov, N.V. Il’in, L.O. Kashintseva, E.V. Kondakova, P.V. Kotselyabina, V.A. Lapin, K.V. Lepik, I.V. Lesechko, V.M. Moiseenko, G.M. Manikhas, N.V. Medvedeva, Yu.A. Oleinik, E.S. Pavlyuchenko, K.S. Parfenova, E.V. Patrakova, A.V. Proidakov, D.V. Saidullaeva, E.V. Tarasova, A.L. Shipaeva, T.V. Shneider, B.V. Afanasyev

  455-465

  01.10.2021

• Carmustine in the Therapy of B-Cell Lymphomas

  Daria Aleksandrovna Koroleva, E.E. Zvonkov

  496-502

  01.10.2021

• Molecular Profiling and Minimal Residual Disease Monitoring in Multiple Myeloma Patients: A Literature Review

  Aleksandra Vladimirovna Semyanikhina, E.E. Tolstykh

  436-443

  01.10.2021

• Pharmacoeconomic Analysis of R-DA-EPOCH and R-mNHL-BFM-90 Combination Immunochemotherapy in Patients with Prognostically Unfavorable Diffuse Large B-Cell Lymphoma within Randomized Multi-Center Clinical Trial DLBCL-2015

  Madina Olegovna Bagova, A.U. Magomedova, S.K. Kravchenko, R.I. Yagudina, V.G. Serpik, S.M. Kulikov, Yu.A. Chabaeva

  321-332

  01.07.2021

• Efficacy, Safety, and Tolerance of Gemtuzumab Ozogamicin Combined with FLAG/FLAG-Ida or Azacitidine in Relapsed/Refractory Acute Myeloblastic Leukemia

  Irina Garmaevna Budaeva, D.V. Zaitsev, A.A. Shatilova, E.N. Tochenaya, A.V. Petrov, R.I. Vabishchevich, D.V. Motorin, R.Sh. Badaev, D.B. Zammoeva, V.V. Ivanov, S.V. Efremova, K.V. Bogdanov, Yu.V. Mirolyubova, T.S. Nikulina, Yu.A. Alekseeva, A.Yu. Zaritskey, L.L. Girshova

  299-307

  01.07.2021

• Value of PD-L1 Protein Expression in the Combined Prognostic Model of Diffuse Large B-Cell Lymphoma

  Svetlana Valerevna Samarina, N.Yu. Semenova, N.V. Minaeva, D.A. Dyakonov, V.A. Rosin, E.V. Vaneeva, S.V. Gritsaev

  308-314

  01.07.2021

• Obesity as a Poor Prognostic Factor in Multiple Myeloma

  Evgenii Sergeevich Mikhailov, G.N. Salogub, S.S. Bessmeltsev

  315-320

  01.07.2021

• Potential Predictors and Response Quality after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

  Ivan Ivanovich Kostroma, Zh.Yu. Sidorova, N.Yu. Semenova, A.A. Zhernyakova, R.R. Sabitova, S.P. Svitina, E.I. Stepchenkova, S.S. Bessmeltsev, A.V. Chechetkin, S.V. Gritsaev

  333-339

  01.07.2021

• Polymorphism of Interleukins and Tumor Necrosis Factor α Genes in Multiple Myeloma Patients with Autologous Hematopoietic Stem Cell Transplantation

  Svetlana Pavlovna Svitina, Zh.Yu. Sidorova, I.I. Kostroma, A.A. Zhernyakova, A.V. Chechetkin, Zh.V. Chubukina, S.V. Gritsaev, S.I. Kapustin, S.S. Bessmeltsev

  340-346

  01.07.2021